Hepatitis Monthly

Published by: Kowsar

Vaccination Against Hepatitis A for Hemophilic Patients: Is It Necessary?

Jamal Mirzaei 1 , Masood Ziaee 2 , * , Seyed Ali Farsad 1 , Mohammad Fereydooni 3 , Gholamreza Anani Sarab 2 and Mohammad Reza Rezvani Khorashad 4
Authors Information
1 Infectious Disease Research Center, AJA University of Medical Sciences, Tehran, IR Iran
2 Hepatitis Research Center, Birjand University of Medical Sciences, Birjand, IR Iran
3 Asthma, Allergy and Immunology Research Center, Birjand University of Medical Sciences, Birjand, IR Iran
4 Diabetes Research center, Department of Internal Medicine, Birjand University of Medical Sciences, Birjand, IR Iran
Article information
  • Hepatitis Monthly: April 01, 2016, 16 (4); e37447
  • Published Online: April 5, 2016
  • Article Type: Research Article
  • Received: February 29, 2016
  • Accepted: March 8, 2016
  • DOI: 10.5812/hepatmon.37447

To Cite: Mirzaei J, Ziaee M, Farsad S A, Fereydooni M, Anani Sarab G, et al. Vaccination Against Hepatitis A for Hemophilic Patients: Is It Necessary?, Hepat Mon. 2016 ; 16(4):e37447. doi: 10.5812/hepatmon.37447.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. SAGE Hepatitis A Working Group . Evidence based recommendations for use of hepatitis A vaccines in immunization services: Background paper for SAGE discussions. WHO. 2011; : 1-12
  • 2. Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev. 2001; 14(1): 38-58[DOI][PubMed]
  • 3. Hussain Z. Genomic Heterogeneity of Hepatitis Viruses (AE): Role in Clinical Implications and Treatment. Pract Manage Chronic Viral Hepat. 2013;
  • 4. Poovorawan Y, Chatchatee P, Chongsrisawat V. Epidemiology and prophylaxis of viral hepatitis: a global perspective. J Gastroenterol Hepatol. 2002; 17 Suppl-66[PubMed]
  • 5. Vitral CL, Ospina FL, Artimos S, Melgaco JG, Cruz OG, de Paula VS, et al. Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil. Mem Inst Oswaldo Cruz. 2012; 107(5): 652-8[PubMed]
  • 6. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine. 2000; 18 Suppl 1-60[PubMed]
  • 7. Chen JY, Chiang JC, Lu SN, Hung SF, Kao JT, Yen YH, et al. Changing prevalence of anti-hepatitis A virus in adolescents in a rural township in Taiwan. Chang Gung Med J. 2010; 33(3): 321-6[PubMed]
  • 8. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004; 132(6): 1005-22[PubMed]
  • 9. Lee A, Lim HS, Nam CM, Song SM, Yoon HR, Lee KR. [An epidemiological analysis of hepatitis A virus serologic markers during the recent four years in Korea]. Korean J Lab Med. 2009; 29(6): 563-9[DOI][PubMed]
  • 10. Brundage SC, Fitzpatrick AN. Hepatitis A. Am Fam Physician. 2006; 73(12): 2162-8[PubMed]
  • 11. Atkinson W. Epidemiology and prevention of vaccine-preventable diseases. 2005;
  • 12. Tantawy AA, Algohary EA, El-Ghany SM, Elhadary SF. Haemophilia A patients are not at increased risk of hepatitis A virus infection: An Egyptian experience. Egyptian J Med Human Genet. 2012; 13(1): 93-7
  • 13. Richardson LC, Evatt BL. Risk of hepatitis A virus infection in persons with hemophilia receiving plasma-derived products. Transfus Med Rev. 2000; 14(1): 64-73[PubMed]
  • 14. Mauser-Bunschoten EP, Damen M, Zaaijer HL, Sjerps M, Roosendaal G, Lelie PN, et al. Hepatitis G virus RNA and hepatitis G virus-E2 antibodies in Dutch hemophilia patients in relation to transfusion history. Blood. 1998; 92(6): 2164-8[PubMed]
  • 15. Samimi-Rad K, Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia. 2007; 13(2): 156-63[DOI][PubMed]
  • 16. Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013; 19(1)-47[DOI][PubMed]
  • 17. Cho SE, Kim Y. Seroepidemiology of hepatitis a in South Korea: a nationwide study by the Eone Reference Laboratory. J Epidemiol. 2013; 23(4): 270-4[PubMed]
  • 18. Molina R, Lorenzo JI, Gomez MD, Sarrion A, Haya S, Querol F, et al. [Seroprevalence of hepatitis A in hemophiliacs]. Sangre (Barc). 1996; 41(5): 363-5[PubMed]
  • 19. Mauser-Bunschoten EP, Zaaijer HL, van Drimmelen AA, van den Berg HM, Roosendaal G, Lelie PN. Risk of hepatitis A in Dutch hemophilia patients. Thromb Haemost. 1995; 74(2): 616-8[PubMed]
  • 20. Hayashi K, Fukuda Y, Nakano I, Katano Y, Nagano K, Yokozaki S, et al. Infection of hepatitis A virus in Japanese haemophiliacs. J Infect. 2001; 42(1): 57-60[DOI][PubMed]
  • 21. Taghavi Ardakani A, Soltani B, Sehat M, Namjoo S, Haji Rezaei M. Seroprevalence of anti-hepatitis a antibody among 1 - 15 year old children in kashan-iran. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 22. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010; 13(2): 99-104[PubMed]
  • 23. Saberifiroozi M. Hepatitis A virus infection: Is it an important hazard to public health?: hazards of HAV for public health. Hepat Mon. 2011; 11(4): 235-7[PubMed]
  • 24. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population--a viral marker study. Ann Acad Med Singapore. 1980; 9(2): 144-8[PubMed]
  • 25. Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z, et al. HAV in Isfahan province: a population-based study. Trop Gastroenterol. 2008; 29(3): 160-2[PubMed]
  • 26. Masuet-Aumatell C, Ramon-Torrell JM, Casanova-Rituerto A, Banque-Navarro M, Davalos-Gamboa M, Montano-Rodriguez SL. Prevalence of hepatitis A antibodies in Eastern Bolivia: a population-based study. J Med Virol. 2013; 85(10): 1692-7[DOI][PubMed]
  • 27. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011; 11(4): 285-8[PubMed]
  • 28. Chambost H, Doncarli A, Bertrand MA, Briquel ME, Gay V, Pincemaille O, et al. Implementation of a hepatitis A prevention policy in haemophiliacs: results from the French cohort. Haemophilia. 2007; 13(6): 712-21[DOI][PubMed]
  • 29. Rafiei A, Darzyani AM, Taheri S, Haghshenas MR, Hosseinian A, Makhlough A. Genetic diversity of HCV among various high risk populations (IDAs, thalassemia, hemophilia, HD patients) in Iran. Asian Pac J Trop Med. 2013; 6(7): 556-60[DOI][PubMed]
  • 30. Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013; 13(1)[DOI][PubMed]
  • 31. Jamil LH, Duffy MC, Fakhouri M, Jamil HJ. Prevalence of antibodies to the hepatitis C virus among Arab and Chaldean Americans in southeast Michigan, USA. Ethn Dis. 2013; 23(1): 18-21[PubMed]
  • 32. Kupfer B, Ruf T, Matz B, Nattermann J, Spengler U, Rockstroh JK, et al. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates. J Clin Virol. 2005; 34(1): 42-7[DOI][PubMed]
  • 33. Chakrabarti S, Pradhan P, Roy A, Hira M, Bandyopadhyay G, Bhattacharya DK. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Indian J Public Health. 2006; 50(1): 43-4[PubMed]
  • 34. Alavian S, Ardeshir A, Hajarizadeh B. Seroprevalence of anti-HCV among Iranian hemophilia patients. Transfus Today . : 3-5
  • 35. Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Med J. 2007; 28(10): 1516-9[PubMed]
  • 36. Borhany M, Shamsi T, Boota S, Ali H, Tahir N, Naz A, et al. Transfusion transmitted infections in patients with hemophilia of Karachi, Pakistan. Clin Appl Thromb Hemost. 2011; 17(6): 651-5[DOI][PubMed]
  • 37. Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon. 2011; 11(5): 346-50[PubMed]
  • 38. Ghafouri M, Ameli M. Comparing prevalence of transfusion transmitted viral infections in various population groups of South Khorasan. Sci Iranian Blood Transfus Organiz (Khoon). 2011; 7(29): 242-68
  • 39. Ziaee M, Zarban A, Malekinejad P, Akhbary H. Evaluation of HGV viremia prevalence and its co-infection with HBV, HCV, HIV and HTLV-1 in hemophilic patients of Southern Khorassan, Iran. Hepat Mon. 2007; 7(1): 11-4
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments